SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028633
Filing Date
2016-11-09
Accepted
2016-11-09 16:16:11
Documents
44
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20160930.htm 10-Q 876112
2 EX-31.1 evok-ex311_10.htm EX-31.1 9584
3 EX-31.2 evok-ex312_9.htm EX-31.2 9865
4 EX-32.1 evok-ex321_6.htm EX-32.1 5032
5 EX-32.2 evok-ex322_7.htm EX-32.2 5254
  Complete submission text file 0001564590-16-028633.txt   3310443

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT evok-20160930.xml EX-101.INS 598587
7 XBRL TAXONOMY EXTENSION SCHEMA evok-20160930.xsd EX-101.SCH 31046
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20160930_cal.xml EX-101.CAL 19598
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20160930_def.xml EX-101.DEF 124239
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20160930_lab.xml EX-101.LAB 239090
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20160930_pre.xml EX-101.PRE 193082
Mailing Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 161984437
SIC: 2834 Pharmaceutical Preparations